Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 168-173

  Pieters, Bradley R ^a   de Back, Djuna Z ^a   Koning, Caro C E ^a   Zwinderman, Aeilko H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Brachytherapy; Dose escalated radiotherapy; Meta analysis; Prostate neoplasms; Systematic review

Indexed keywords

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BRACHYTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 70350499495     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.033     Document Type: Review

References (47)

1. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
3. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
4. Demanes D.J., Rodriguez R.R., Schour L., Brandt D., and Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306-1316
5. Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
6. Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study. Int J Radiat Oncol Biol Phys 66 (2006) 416-423
7. Guix B., Bartrina J.M., Henriquez I., et al. Dose escalation by combined treatment 3D-conformal radiotherapy plus HDR brachytherapy as treatment for intermediate- or high-risk cancer: early toxicity and biochemical outcome of a prospective randomized trial. Radiother Oncol 83 (2007) S39 [abstract 81]
8. Hoskin P.J., Motohashi K., Bownes P., Bryant L., and Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiother Oncol 84 (2007) 114-120
9. American Society for Therapeutic Radiology and Oncology. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
10. Vicini F.A., Horwitz E.M., Kini V.R., Stromberg J.S., and Martinez A.A. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature. Int J Radiat Oncol Biol Phys 40 (1998) 1101-1110
11. Pieters B.R., van de Kamer J.B., van Herten Y.R.J., et al. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. Radiother Oncol 88 (2008) 46-52
12. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology. JAMA 283 (2000) 2008-2012
13. Thames H., Kuban D., Levy L., et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929-943
14. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32 (1995) 3-12
15. Pollack A., Smith L.G., and von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48 (2000) 507-512
16. Kupelian P.A., Reddy C.A., Carlson T.P., Altsman K.A., and Willoughby T.R. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 904-912
17. Zelefsky M.J., Marion C., Fuks Z., and Leibel S.A. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. J Urol 170 (2003) 1828-1832
18. Pollack A., Hanlon A.L., Horwitz E.M., et al. Prostate cancer radiotherapy dose response: an update of the Fox Chase experience. J Urol 171 (2004) 1132-1136
19. Nichol A., Chung P., Lockwood G., et al. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy. Radiother Oncol 76 (2005) 11-17
20. Eade T.N., Hanlon A.L., Horwitz E.M., et al. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 682-689
21. Iversen P., Bak M., Juul N., et al. Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma. Urology 34 (1989) 181-186
22. Kaye K.W., Olson D.J., and Payne J.T. Original articles: prostate cancer: detailed preliminary analysis of iodine-125 implantation for localized prostate cancer using percutaneous approach. J Urol 153 (1995) 1020-1025
23. Critz F.A., Levinson A.K., Williams W.H., et al. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation. Cancer J Sci Am 4 (1998) 359-363
24. Ragde H., Elgamal A.A., Snow P.B., et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. Cancer 83 (1998) 989-1001
25. Lederman G.S., Cavanagh W., Albert P.S., et al. Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy. Int J Radiat Oncol Biol Phys 49 (2001) 1297-1303
26. Potters L., Fearn P., and Kattan M. The role of external radiotherapy in patients treated with permanent prostate brachytherapy. Prostate Cancer Prostatic Dis 5 (2002) 47-53
27. Singh A.M., Gagnon G., Collins B., et al. Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis. Prostate 62 (2005) 54-60
28. Jani A.B., Feinstein J.M., Pasciak R., Krengel S., and Weichselbaum R.R. Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer. Urology 67 (2006) 1007-1011
29. Dattoli M., Wallner K., True L., Cash J., and Sorace R. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension. Urology 69 (2007) 334-337
30. Ellis R.J., Zhou H., Kim E.Y., et al. Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide. Brachytherapy 6 (2007) 16-25
31. Sylvester J.E., Grimm P.D., Blasko J.C., et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 67 (2007) 57-64
32. Merrick G.S., Butler W.M., Wallner K.E., et al. Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam. Int J Radiat Oncol Biol Phys 68 (2007) 34-40
33. Lee W.R., Bae K., Lawton C., et al. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of radiation therapy oncology group study 0019. Cancer 109 (2007) 1506-1512
34. Mate T.P., Gottesman J.E., Hatton J., Gribble M., and Van Hollebeke L. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
35. Pellizzon A.C., Nadalin W., Salvajoli J.V., et al. Results of high dose rate after loading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 66 (2003) 167-172
36. Hiratsuka J., Jo Y., Yoshida K., et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 684-690
37. Martin T., Roddiger S., Kurek R., et al. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol 71 (2004) 35-41
38. Åström L., Pedersen D., Mercke C., Holmang S., and Johansson K.A. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 74 (2005) 157-161
39. Deger S., Boehmer D., Roigas J., et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 47 (2005) 441-448
40. Hsu I.C., Cabrera A.R., Weinberg V., et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 4 (2005) 202-206
41. Chin Y.S., Bullard J., Bryant L., et al. High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. Clin Oncol 18 (2006) 474-479
42. Izard M.A., Haddad R.L., Fogarty G.B., et al. Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci 192Ir source, and neoadjuvant hormonal manipulation for prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 38-47
43. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 5 (2006) 157-164
44. Rades D., Schwarz R., Todorovic M., et al. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer. Strahlenther Onkol 183 (2007) 398-402
45. Phan T.P., Syed A.M.N., Puthawala A., Sharma A., and Khan F. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer. J Urol 177 (2007) 123-127
46. Kälkner K.M., Wahlgren T., Ryberg M., et al. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up. Acta Oncol 46 (2007) 909-917
47. Chen Y.C., Chuang C.K., Hsieh M.L., et al. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan. Urology 70 (2007) 101-105